Selected patients may choose a personalized C-ACT protocol that include low-dose chemotherapy. However, for patients who have become resistant to chemo drugs that were previously effective, Oasis of Hope employs a strategy known as epigenetic therapy which involves the safe drug valproate and hydralazine, to re-establish treatment sensitivity.
Patients on the C-ACT also receive several courses of intravenous vitamin C therapy to kill more of the cancer cells with severe tumor-specific oxidative stress.
For patients who do not elect to have chemotherapy or for whom chemotherapy would appear to be a poor option, the alternative protocol offers a more intense series of intravenous vitamin C sessions.
Intravenous vitamin C therapy at Oasis is distinguished by novel adjunctive features such as ozone autohemotherapy and perfect administration of vitamin k and laetrile to boost tumor oxygenation and catalyze oxidant generation and maximize cancer killing cells.